Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Adonis›
Analysis
AddedFeb 15, 2024
UpdatedJun 12, 2026
Adonis

Adonis

Series C

Adonis is an AI orchestration platform for healthcare revenue cycle management.

HQ
New York City, NY, US
Founded
2022
Loading
Overview
Analysis
Compare
Fundraising
Employees
News
Website
Number of Customers
10,000

Contents

  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths
  1. 01Products & Services
  2. 02Market Outlook
  3. 03Competitive Strengths

Product Overview

Adonis provides an AI-powered revenue cycle management platform for healthcare providers. The platform consists of two core products: Adonis Intelligence and Adonis AI Agent.

Adonis Intelligence monitors submitted and remitted claims to identify revenue risks, detect underpayments, and flag denials before they impact cash flow. Adonis AI Agent automates resolution workflows across payer friction, claims delays, and denial management without requiring manual intervention.

Adonis offers an AI orchestration platform for healthcare revenue cycle management. Its flagship product, Adonis Intelligence, serves as the engine powering dramatic reductions in staffing needs and improved collections outcomes.

The company's AI Agent products proactively monitor revenue cycle issues, recommend tailored actions, and autonomously progress claims to resolution. The platform integrates with over 35 EHRs and clearinghouses and processes claims across more than 3,000 payers.

Adonis offers an AI orchestration platform for healthcare revenue cycle management built around two core products: Adonis Intelligence and Adonis AI Agents. Intelligence serves as the monitoring and analytics engine, providing real-time dashboards, alerts, AI-driven recommendations, claims status tracking, smart worklists, and underpayment detection.

AI Agents extend the platform by autonomously detecting revenue cycle issues, recommending tailored actions, and progressing claims to resolution without manual intervention. The platform integrates with over 35 EHRs and clearinghouses, connects to payer portals, and serves health systems, physician groups, and digital health companies across multiple specialties.

Market Outlook

The healthcare revenue cycle management market is expanding as provider margins tighten and payer complexity increases. AI-driven RCM solutions are gaining traction as health systems seek to reduce administrative costs and accelerate cash collection.

Adonis is positioned to capture share in this growing market by replacing legacy rules-based systems with adaptive AI that learns from each organization's unique payer mix and claims patterns. The company's Series C funding will support continued product development and market expansion.

The healthcare revenue cycle management market faces growing complexity from evolving payer policies, rising denial rates, and workforce constraints. Providers lose up to 15 percent or more of potential revenue due to these operational challenges.

Adonis targets this market by providing AI-native infrastructure that learns from millions of claims to improve collections, reduce rework, and relieve overburdened teams. The company is expanding its presence in the health system market and growing its New York City-based team.

The healthcare revenue cycle management market faces intensifying pressure from rising payer denial rates, evolving reimbursement policies, and workforce shortages. Recent policy changes, including Medicaid and ACA subsidy shifts, have increased the number of uninsured and self-pay patients while adding complexity to reimbursement requirements.

Healthcare providers currently lose up to 15% or more of potential revenue due to compounding inefficiencies across people, processes, and systems. AI and agentic automation are emerging as critical infrastructure to address these structural challenges, with health systems seeking predictability and accountability that legacy tools were never designed to provide. Adonis is positioned at the intersection of this shift toward autonomous RCM operations.

Competitive Advantages

Adonis differentiates itself through proprietary machine learning models trained on millions of claims records, enabling predictive identification of root-cause revenue issues before they escalate. The platform combines intelligence and autonomous agent capabilities in a single orchestration layer, rather than offering static rule-based tools.

The human-in-the-loop design gives healthcare CIOs and CFOs governance and accountability as they adopt AI. Adonis processes tens of millions of claims totaling over $13 billion in charges, works with more than 10,000 providers and nearly all US payers, creating a data network effect that continuously improves recommendations and automation outcomes.

Adonis differentiates itself through deep AI orchestration purpose-built for healthcare revenue cycle operations. Unlike generic automation tools, Adonis trains its models on healthcare-specific claims and remittance data.

The platform integrates directly with existing practice management and EHR systems, requiring no infrastructure overhaul. Adonis Intelligence detects underpayments that traditional RCM software misses, while Adonis AI Agent resolves issues autonomously rather than simply alerting staff to problems.

Adonis differentiates itself through proprietary AI models trained on millions of claims. This enables pattern recognition and anomaly detection that static rule-based systems cannot match.

The platform's human-in-the-loop design gives healthcare executives governance and accountability while automating complex workflows. Its deep integrations across the healthcare billing ecosystem create significant switching costs for customers.